Inactive Instrument

Sector Chart Cell Source, Inc. Other OTC

Equities

CLCS

US15114L1044

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
12TCr
11TCr
2.27TCr -
2.08TCr -
1.67TCr